首页|吲哚布芬联合穴位贴敷预防肾病综合征静脉血栓的疗效观察

吲哚布芬联合穴位贴敷预防肾病综合征静脉血栓的疗效观察

扫码查看
目的 研究分析吲哚布芬联合穴位贴敷预防肾病综合征静脉血栓的疗效。方法 回顾性分析2021年6月至2023年1月九江市中医医院收治的90例肾病综合征患者的临床资料,根据治疗方式的不同分为A、B和C组,每组各30例。A组患者采取吲哚布芬治疗;B组患者在A组基础上,联合穴位贴敷治疗;C组患者给予阿司匹林肠溶片治疗。比较三组患者的临床疗效、凝血指标[活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、纤维蛋白原(FIB)水平,D-二聚体(D-D)]、肾脏指标[血尿素氮(BUN)和血肌酐(SCr)]和不良反应和静脉血栓发生率。结果 治疗后,三组患者治疗后的临床疗效、凝血指标和BUN水平比较,差异有统计学意义(P<0。05)。B组临床治疗总有效率高于A组和C组,差异有统计学意义(P<0。017)。B组的APTT和PT长于A组和C组,FIB、D-D、BUN水平均低于A组和C组,差异有统计学意义(P<0。05)。三组患者的不良反应总发生率比较,差异无统计学意义(P>0。05)。三组的静脉血栓发生率比较,差异有统计学意义(P<0。05);但进一步两两比较,差异无统计学意义(P>0。017)。结论 在肾病综合征治疗中,采用吲哚布芬联合穴位贴敷能够降低静脉血栓的发生风险,促进局部血运,且安全性良好。
Clinical observation of Indobufen combined with acupoint application in preventing venous thrombosis in nephrotic syndrome
Objective To study and analyze the efficacy of Indobufen combined with acupoint application in preventing ve-nous thrombosis in nephrotic syndrome.Methods The clinical data of 90 patients with nephrotic syndrome admitted to Jiu-jiang Hospital of Traditional Chinese Medicine from June 2021 to January 2023 were retrospectively analyzed.According to the different treatment methods,they were divided into group A,B and C,with 30 cases in each group.Patients in group A were treated with Indobufen,patients in group B were treated with acupoint application on the basis of group A,and patients in group C were treated with Aspirin Enteric-coated Tablets.The clinical efficacy,coagulation indexes(activated partial thromboplastin time[APTT],prothrombin time[PT],fibrinogen[FIB]level,D-dimer[D-D]),renal indexes(blood urea ni-trogen[BUN]and serum creatinine[SCr]),adverse reactions and incidence of venous thrombosis were compared among the three groups.Results After treatment,there were statistically significant differences in clinical efficacy,coagulation indexes and BUN levels among the three groups(P<0.05).The total effective rate of group B was higher than that of group A and group C,and the difference was statistically significant(P<0.017).The APTT and PT of group B were longer than those of group A and group C,while FIB,D-D and BUN were lower than those of group A and group C,and the differences were statistically significant(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions among the three groups(P>0.05).There was statistically significant difference in the incidence of venous thrombosis among the three groups(P<0.05).However,there was no significant difference between any two groups(P>0.017).Conclusion In the treatment of nephrotic syndrome,indobufen combined with acupoint application can reduce the risk of venous thrombo-sis,promote local blood supply,and has good safety.

IndobufenAcupoint applicationNephrotic syndromeVenous thrombosis

刘星宇、段崇毅、黄红恩、刘永芳、章江川、雷兵、余敏锋、林雪菲

展开 >

江西省九江市中医医院肾内科,江西九江 332000

江西省九江市中医医院影像科,江西九江 332000

吲哚布芬 穴位贴敷 肾病综合征 静脉血栓

江西省卫生健康委科技计划项目

202311580

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(7)
  • 20